Clal Biotechnology | CBI - Trade Creditors


Clal Biotechnology reported ILS21.05M in Trade Creditors for its fiscal quarter ending in December of 2021.





Trade Creditors Change Date
Arca Biopharma USD 4.16M 1.95M Dec/2025
aTyr Pharma USD 55.07M 51.01M Dec/2025
Bio Path USD 4.9M 1.42M Sep/2025
Brainstorm Cell Therapeutics USD 7.07M 647K Dec/2025
Cara Therapeutics USD 4.08M 1.65M Sep/2025
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.35M 6.77M Dec/2025
Immunic USD 7.92M 25K Sep/2025
Infinity Pharmaceuticals USD 1.5M 433K Jun/2023
Minerva Neurosciences USD 640K 305K Dec/2025
RedHill Biopharma USD 835K 7.03M Jun/2025
TherapeuticsMD USD 143K 4K Jun/2024